Leadless pacemaker for heart failure resynchronization
Part of Heart & circulation clinical trials.
This trial tests a completely leadless pacemaker (WiSE® CRT) for heart failure patients who need cardiac resynchronization therapy (CRT). It aims to avoid the long-term risks of traditional wires (leads) in the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a low ejection fraction (≤35%) and a specific type of electrical delay in your heart (wide QRS).
- You are either getting a new CRT device or upgrading from an existing pacemaker to a CRT device.
- You are 22 years old or older.
- You are not pregnant, nursing, or planning pregnancy during the study.
- You have a life expectancy of at least 12 months.
- You can attend follow-up visits and follow study requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a heart device (CRT) that coordinates your heart's contractions, combined with a new electrical mapping technique to place leads more precisely. It's designed for people with weak heart function and abnormal electrical patterns who haven't improved enough with medications alone.
This trial compares two types of pacemaker placement to improve heart function in people with heart failure. One method paces the heart's natural conduction system, while the other paces the lower chambers of the heart. The goal is to find which approach works better for heart resynchronization therapy.
This study tests a new heart scan method to help doctors improve pacemaker treatment for people with heart failure. If you already qualify for a special pacemaker called CRT, this scan may make the treatment work better for you.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This trial tests whether a different pacing approach called left bundle branch pacing can improve outcomes and heart structure changes in people who did not improve with standard biventricular CRT. It may help some patients with ongoing heart failure symptoms and weak heart pumping.
This trial evaluates a noninvasive way to assess who should get Cardiac Resynchronization Therapy (CRT), and to check results after implantation. If you fit the heart rhythm and heart pump criteria, the approach may help confirm whether CRT is appropriate for you.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.